Simplex Trading’s Entera Bio ENTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.78K Buy
+2,700
New +$3.38K ﹤0.01% 8204
2023
Q1
Sell
-1,400
Closed -$1K 9286
2022
Q4
$1K Hold
1,400
﹤0.01% 8813
2022
Q3
$1K Hold
1,400
﹤0.01% 9517
2022
Q2
$1K Sell
1,400
-100
-7% -$222 ﹤0.01% 9560
2022
Q1
$4K Sell
1,500
-4,900
-77% -$11.8K ﹤0.01% 9542
2021
Q4
$18K Sell
6,400
-300
-4% -$1.12K ﹤0.01% 8465
2021
Q3
$42K Sell
6,700
-3,900
-37% -$20K ﹤0.01% 7722
2021
Q2
$63K Buy
+10,600
New +$39.2K ﹤0.01% 7360

Other funds holding ENTX

Simplex Trading's ENTX Position: Q2 2026 in Review

Simplex Trading opened a new position in Entera Bio (ENTX) in Q2 2026: 15,698 shares worth $27.8K. The stake represents ﹤0.01% of the portfolio and ranks #6820 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ENTX as recently as Q3 2025.

Simplex Trading first reported a position in ENTX in Q2 2021 and has held it in 10 quarters since. The position peaked at $122K in Q3 2021. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Simplex Trading held 15,698 shares of Entera Bio worth $27.8K as of Q2 2026.
  • Entera Bio was a new Simplex Trading position in Q2 2026.
  • Entera Bio made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6820 holding.
  • Simplex Trading first reported a position in Entera Bio in Q2 2021 and has held it in 10 quarters since.
  • Simplex Trading's Entera Bio position peaked at $122K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.